Case examples

Real AIRAscore analysis reports for typical conditions. Choose a case and page through the report.

Early Alzheimer's disease

Hippocampus and amygdala on both sides, right temporal lobe reduced

Abnormal values in this case

  • Temporal (R) percentile 0.2
  • Hippocampus (R) percentile 0.7
  • Hippocampus (L) percentile 0.8
  • Amygdala (L) percentile 0.6
  • Amygdala (R) percentile 0.9

The volume loss mainly affects the medial temporal lobe, with hippocampus and amygdala on both sides, plus the right temporal lobe. Frontal, parietal and occipital lobes are within the normal range. Medial temporal lobe atrophy is a marker of Alzheimer’s disease, already at the stage of mild cognitive impairment.1,2 When hippocampus and amygdala are clearly more affected than the rest of the cortex, this fits the limbic-predominant form.3 Such patterns are typical tendencies. Overlap and mixed pathology occur, so the pattern is always read together with the clinical picture and other findings.

Report as PDF · 1.3 MB

female, 68 years · Software 3.0.1 · Siemens Prisma fit 3 T

Page 1 of 6

Tissue classes and infratentorial structures

The header holds the order ID, the time of the MRI scan and of the analysis, the software version and the key sequence parameters. Below, each structure is listed as absolute volume in ml and as a share of the total intracranial volume (%TIV) with its percentile. The bar shows the normal range, corrected for head size, age and sex, and the asterisk marks the measured value.

The results of an analysis report must be checked for plausibility and correctness by a qualified physician (specialist) before clinical assessment. The reports come from software version 3.0.1. The current version is 3.1.0.

Sources (3)
  1. Frisoni GB, Fox NC, Jack CR Jr, Scheltens P, Thompson PM. The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 2010; 6: 67–77. Source
  2. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011; 7: 263–269. Source
  3. Whitwell JL, Dickson DW, Murray ME, et al. Neuroimaging correlates of pathologically defined subtypes of Alzheimer’s disease: a case-control study. Lancet Neurol 2012; 11: 868–877. Source